There has been increasing interest in dissecting the relative contributions of hyperglycemia and hypoinsulinemia to the pathophysiology of diabetes and diabetes complications because current treatments for diabetes fail to normalize metabolism or eliminate the risk of complications, and hypoglycemia limits the use of intensive insulin therapy [1]. This evidence concerns the gene INS and Hyperglycemia.